Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Teva
Covington
Federal Trade Commission
Accenture
Baxter
Healthtrust
Queensland Health
QuintilesIMS

Generated: June 22, 2018

DrugPatentWatch Database Preview

Betaxolol hydrochloride; chlorthalidone - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for betaxolol hydrochloride; chlorthalidone and what is the scope of betaxolol hydrochloride; chlorthalidone patent protection?

Betaxolol hydrochloride; chlorthalidone
is the generic ingredient in one branded drug marketed by Sanofi Aventis Us and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for betaxolol hydrochloride; chlorthalidone.
Summary for betaxolol hydrochloride; chlorthalidone
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 11
Clinical Trials: 53
DailyMed Link:betaxolol hydrochloride; chlorthalidone at DailyMed

US Patents and Regulatory Information for betaxolol hydrochloride; chlorthalidone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us KERLEDEX betaxolol hydrochloride; chlorthalidone TABLET;ORAL 019807-001 Oct 30, 1992 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sanofi Aventis Us KERLEDEX betaxolol hydrochloride; chlorthalidone TABLET;ORAL 019807-002 Oct 30, 1992 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for betaxolol hydrochloride; chlorthalidone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us KERLEDEX betaxolol hydrochloride; chlorthalidone TABLET;ORAL 019807-002 Oct 30, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Sanofi Aventis Us KERLEDEX betaxolol hydrochloride; chlorthalidone TABLET;ORAL 019807-001 Oct 30, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Sanofi Aventis Us KERLEDEX betaxolol hydrochloride; chlorthalidone TABLET;ORAL 019807-002 Oct 30, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Sanofi Aventis Us KERLEDEX betaxolol hydrochloride; chlorthalidone TABLET;ORAL 019807-001 Oct 30, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Cerilliant
US Army
Chubb
Argus Health
Fish and Richardson
Daiichi Sankyo
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.